找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Lung Cancer and Personalized Medicine; Current Knowledge an Aamir Ahmad,Shirish Gadgeel Book 2016 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: 導(dǎo)彈
31#
發(fā)表于 2025-3-26 22:38:25 | 只看該作者
32#
發(fā)表于 2025-3-27 02:04:18 | 只看該作者
Bernhard Biersack,Rainer Schobert emission band. Instead, crests and crevices, rifts and ridges showed up in the recorded spectra. Soon these observed features were traced to either very weak absorption of matter or spurious interference inside the laser resonator [1]. This interpretation suggested that this ultra-sensitive respons
33#
發(fā)表于 2025-3-27 09:08:48 | 只看該作者
34#
發(fā)表于 2025-3-27 11:07:34 | 只看該作者
35#
發(fā)表于 2025-3-27 13:39:28 | 只看該作者
36#
發(fā)表于 2025-3-27 20:52:55 | 只看該作者
37#
發(fā)表于 2025-3-28 00:02:07 | 只看該作者
Immune Therapy,as shown that anti-tumor immune responses can occur in lung cancer patients, paving the way for lung cancer as a novel target for immunotherapy. In order to take full advantage of the potential of immunotherapy, research is focusing on the presence and function of various immunological cell types in
38#
發(fā)表于 2025-3-28 02:28:28 | 只看該作者
39#
發(fā)表于 2025-3-28 09:10:08 | 只看該作者
Target Therapy in Lung Cancer, Health Organization (WHO) typing system [1]. Because these variants have differing genetic and biological properties correct classification of lung cancer is necessary to assure that lung cancer patients receive optimum management. Due to the recent understanding that histologic typing and . mutati
40#
發(fā)表于 2025-3-28 11:30:41 | 只看該作者
Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: An Update, mechanisms namely secondary mutation T790M in EGFR and cMET amplification. Other molecular mediators which contribute towards TKI resistance include the activation of compensatory growth signaling, epithelial mesenchymal transition and microRNAs regulating EGFR and cMET levels. In this chapter, we
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 09:29
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
阿克| 栾城县| 榆社县| 平南县| 嘉禾县| 兖州市| 万全县| 多伦县| 塘沽区| 达尔| 蕲春县| 登封市| 维西| 米易县| 社旗县| 岳普湖县| 竹北市| 中山市| 洪洞县| 什邡市| 瑞丽市| 根河市| 阳原县| 黔西县| 长海县| 蓬安县| 汤原县| 泰宁县| 仙桃市| 个旧市| 阿拉善右旗| 利辛县| 舞钢市| 邹城市| 东阿县| 扎鲁特旗| 阜城县| 乌兰察布市| 黄龙县| 额敏县| 安国市|